The independent source for health policy research, polling, and news.
61 - 80 of 469 Results
“Citizen oversight is a cornerstone of a functioning democracy,” Oregon Sen. Ron Wyden wrote to Health and Human Services Secretary Robert F. Kennedy Jr., demanding answers to more than two dozen questions, including who was involved in decisions to fire staff who handled Freedom of Information Act requests.
To a great extent, the FDA leaves it to food companies to determine whether their ingredients and additives are safe. Some chemicals and additives are tied to health risks while others are absent from product labels. Watch this video explainer to learn more.
At least some workers who process public records in response to Freedom of Information Act requests have been reinstated, agency employees say.
A purge of FDA staff spared some people tasked with responding to a judge’s orders to disclose government records on covid vaccines, according to agency employees. The FOIA litigation was brought by Aaron Siri, an ally of Health and Human Services Secretary Robert F. Kennedy Jr.'s who represents anti-vaccine interests.
The Department of Health and Human Services’ mass firings included people who fulfill Freedom of Information Act requests for the Centers for Disease Control and Prevention, National Institutes of Health, and FDA, which result in the release of records about government handling of infectious diseases, medical products, and safety problems in health facilities.
The Department of Health and Human Services underwent an unprecedented purge this week, as thousands of employees from the National Institutes of Health, the FDA, the Centers for Disease Control and Prevention, and other agencies were fired, placed on administrative leave, or offered transfers to far-flung Indian Health Service facilities. Altogether, the layoffs mean the federal government, in a single day, shed hundreds if not thousands of combined years of health and science expertise. Lauren Weber of The Washington Post, Rachel Cohrs Zhang of Bloomberg News, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss this enormous breaking story and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature about a short-term health plan and a very expensive colonoscopy.
KFF Health News gives readers a chance to comment on a recent batch of stories.
With the first licenses for providing psychedelic mushrooms issued, excitement and questions build about the fungi’s potential, affordability, and safety in the Centennial State.
It’s the Trump administration vs. the federal courts, as the Department of Government Efficiency continues to try to cancel federal contracts and programs and fire workers. But in the haste to cut things, jobs and programs are being eliminated even if they align with the new administration’s goal to “Make America Healthy Again.” Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of the Pink Sheet, and Rachel Roubein of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
Almost 40 years ago, Joseph Borzelleca published a study on red dye No. 3, a petroleum-based food coloring. The FDA cited his work to ban the additive in January. But Borzelleca says it’s safe.
A bill proposed by kratom industry advocates is prompting consideration — and some concern — in the Montana Legislature.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Republicans have proposed legislation in several states to ban the pioneering technology used in covid shots. Many doctors worry a huge medical advance could be rolled back.
The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and additives are tied to health risks while others are absent from product labels.
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
The Supreme Court opined for the first time that Trump administration officials may be exceeding their authority to reshape the federal government by refusing to honor completed contracts, even as lower-court judges started blocking efforts to fire workers, freeze funding, and cancel ongoing contracts. Meanwhile, public health officials are alarmed at the Department of Health and Human Services’ public handling of Texas’ widening measles outbreak, particularly the secretary’s less-than-full endorsement of vaccines. Lauren Weber of The Washington Post, Joanne Kenen of the Johns Hopkins University School of Public Health and Politico Magazine, and Stephanie Armour of KFF Health News join KFF Health News’ Julie Rovner to discuss these stories and more.
President Donald Trump has said he won’t support major cuts to the Medicaid health insurance program for people with low incomes, but he has endorsed a House budget plan that calls for major cuts, leaving the program’s future in doubt. Meanwhile, thousands of workers at the Department of Health and Human Services were fired over the holiday weekend, from the National Institutes of Health, the FDA, and the Centers for Disease Control and Prevention, with possibly more cuts to come.
Alice Miranda Ollstein of Politico, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more.
President Donald Trump’s choice to lead the vast Department of Health and Human Services, Robert F. Kennedy Jr., faced sharp questioning from senators this week, particularly over his history of vaccine denialism. Meanwhile, the Trump administration’s second week has been even more disruptive than its first, with an on-again, off-again funding freeze that left many around the country scrambling to understand what was going on. Sandhya Raman of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Nicholas Bagley, a University of Michigan law professor, who explains how the federal regulatory system is supposed to operate to make health policy.
Controversy over raw milk reflects the push-pull the Trump administration faces in rolling back regulations and offering consumers more choices. For now, the CDC still recommends against consuming raw milk and the FDA bans its interstate sale.
© 2026 KFF